{"schemaVersion":"1.0","publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topic":"biology","availableTopics":[{"slug":"robotics","label":"Robotics"},{"slug":"open-models","label":"Open models"},{"slug":"data-centers","label":"Data centers"},{"slug":"biology","label":"Biology"},{"slug":"agents","label":"Agents"}],"total":21,"items":[{"id":"biohub-virtual-biology-coalition","headline":"A $1.8 billion biology coalition tackles AI’s missing experimental data","canonicalUrl":"https://brightaifuture.com/discoveries/biohub-virtual-biology-coalition","datePublished":"2026-10-07","dateModified":null,"sourcePublicationDate":"2026-10-07","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"New experiments, measurement technology and shared standards could help researchers predict how cells respond to interventions and choose better laboratory experiments.","evidenceState":"Emerging","keyFacts":[{"label":"AI’s role","value":"Planned predictive models would learn from standardized experimental data to forecast cellular responses and prioritize laboratory hypotheses."},{"label":"Documented result","value":"Biohub, the U.S. Department of Energy, the National Institutes of Health, Google DeepMind, Isomorphic Labs and Meta announced an expanded effort on October 7 to build the experimental data that predictive models of biology need. The coalition puts a reported $1.8 billion of funding, data, computing and measurement technology behind the Virtual Biology Initiative. S1"},{"label":"Important limitation","value":"Today’s announcement establishes a coordinated commitment. It does not report a newly completed universal cell model, a clinical result or a treatment ready for patients. S1"}],"limitations":["Today’s announcement establishes a coordinated commitment. It does not report a newly completed universal cell model, a clinical result or a treatment ready for patients. S1","Readers should therefore avoid treating the headline as $1.8 billion of newly announced cash. Existing public research resources are part of the package. The companies’ individual contributions are not broken out in the release. S1","Public access is a central promise, but there is an important distinction. Reuters reports that commercially funded datasets will initially be available to the funding companies before public release. Axios reports that this exclusive period is one year. Reuters also reports that the parallel government-funded work will not carry that commercial restriction. S4 S5","The announcements do not supply a comprehensive dataset license, a release-by-release access schedule or a finalized governance charter. A promise of eventual public availability leaves questions about permitted reuse, distribution and how researchers will access the material. Those details deserve scrutiny as the infrastructure takes shape. S1 S3","Crucially, that study did not address prediction in unseen cell types, donors or conditions. A good result on one task cannot establish a universal ability to simulate biology. The distinction matters for models expected to work beyond familiar training examples. S7","Reuters reports that Biohub’s Alex Rives expects a first dataset in about a year and accurate predictive models within five years. These are expectations from the initiative’s scientific leader. The report does not establish a general public-download date for every dataset. S4"],"evidenceLinks":[{"title":"S1 · Biohub: October 7 expansion announcement · 2026-10-07","url":"https://biohub.org/news/virtual-biology-initiative-expansion/","type":"institution"},{"title":"S2 · NIH: NIH joins effort to build SI-ready data for predictive models of human biology · 2026-10-07","url":"https://www.nih.gov/news-events/news-releases/nih-joins-effort-build-si-ready-data-predictive-models-human-biology","type":"institution"},{"title":"S3 · Isomorphic Labs: founding-member announcement and official release PDF · 2026-10-07","url":"https://www.isomorphiclabs.com/articles/isomorphic-labs-joins-the-virtual-biology-initiative","type":"institution"},{"title":"S4 · Reuters / Krystal Hu, syndicated by Investing.com · 2026-10-07","url":"https://www.investing.com/news/stock-market-news/usgovernment-google-join-zuckerbergbacked-biohub-in-18-billion-push-for-ai-biology-data-4936795","type":"report"},{"title":"S5 · Axios / Ina Fried: Zuckerberg teams with Google, U.S. in push to map cells · 2026-10-07","url":"https://www.axios.com/2026/10/07/zuckerberg-biohub-ai-biology-data","type":"report"},{"title":"S6 · Biohub: Virtual Biology Initiative launch · 2026-04-29","url":"https://biohub.org/news/virtual-biology-initiative/","type":"institution"},{"title":"S7 · Miller et al., Nature Biotechnology: Deep learning perturbation models can outperform baselines on calibrated metrics · 2026-10-01","url":"https://www.nature.com/articles/s41587-026-03307-w","type":"paper"},{"title":"S8 · Arc Institute: 2026 Virtual Cell Challenge · 2026-08-20","url":"https://arcinstitute.org/news/virtual-cell-challenge-2026","type":"institution"},{"title":"S9 · NIH: Data Management and Sharing privacy guidance · 2025-08-05","url":"https://www.grants.nih.gov/policy-and-compliance/policy-topics/sharing-policies/dms/privacy","type":"institution"},{"title":"S10 · Biohub-issued release, Newswise DOE Science News Source copy; primary release syndication · 2026-10-07","url":"https://www.newswise.com/doescience/international-cross-sector-collaboration-commits-nearly-2-billion-to-build-foundational-data-for-ai-models-to-predict-and-treat-disease/?article_id=856083","type":"institution"},{"title":"S11 · Biohub-issued release, PRNewswire; primary release distribution · 2026-10-07","url":"https://www.prnewswire.com/news-releases/international-cross-sector-collaboration-commits-nearly-2-billion-to-build-foundational-data-for-ai-models-to-predict-and-treat-disease-302901172.html","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/biohub-virtual-biology-coalition","embedUrl":"https://brightaifuture.com/embed/story/biohub-virtual-biology-coalition","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"alphafold","headline":"Seeing the shape of life.","canonicalUrl":"https://brightaifuture.com/discoveries/alphafold","datePublished":"2026-09-05","dateModified":"2026-09-25","sourcePublicationDate":"2021-07-15","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"Researchers used AlphaFold to predict protein structures with accuracy competitive with experimental structures on many CASP14 targets. Bright's interactive p53 view uses a separate, later AlphaFold DB prediction: human p53 AF-P04637-F1 model v6, created on 2025-08-01.","evidenceState":"Demonstrated","keyFacts":[{"label":"AI’s role","value":"A neural network integrated sequence and structural information to predict three-dimensional structure."},{"label":"Documented result","value":"The 2021 AlphaFold2 paper reported strong performance in the blind CASP14 assessment. On September 24, 2026, AlphaFold Database separately added high-confidence predictions covering 2,812 viral proteomes: 5,279 heterodimers and 2,749 homodimers, plus 4,681 high-confidence homodimers from the separate Viral Assembly Database collection."},{"label":"Important limitation","value":"Predictions carry uncertainty. A predicted structure does not establish function, interaction in a living system, vaccine efficacy or treatment benefit."}],"limitations":["Predictions carry uncertainty. A predicted structure does not establish function, interaction in a living system, vaccine efficacy or treatment benefit.","The viral release is a research resource of predicted dimers, not experimentally validated structures; it does not model glycans, larger assemblies, the effects of genetic variation or host–pathogen interactions.","The p53 view remains a static single-chain prediction, not an experimental structure or a simulation of protein folding.","The p53 model's pLDDT values describe local confidence and do not establish the arrangement of distant regions."],"evidenceLinks":[{"title":"Highly accurate protein structure prediction with AlphaFold · Nature","url":"https://www.nature.com/articles/s41586-021-03819-2","type":"paper"},{"title":"AlphaFold DB human p53 AF-P04637-F1 model v6","url":"https://alphafold.ebi.ac.uk/files/AF-P04637-F1-model_v6.pdb","type":"dataset"},{"title":"AlphaFold Database adds viral protein complexes · EMBL","url":"https://www.embl.org/news/science-technology/alphafold-database-adds-viral-protein-complexes-to-support-pandemic-preparedness/","type":"institution"},{"title":"AlphaFold Database frequently asked questions","url":"https://www.alphafold.ebi.ac.uk/faq","type":"dataset"},{"title":"AlphaFold Database viral protein complex collection","url":"https://alphafold.ebi.ac.uk/","type":"dataset"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/alphafold","embedUrl":"https://brightaifuture.com/embed/story/alphafold","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"eagle-esophageal-ct","headline":"CT scans may carry a second clue.","canonicalUrl":"https://brightaifuture.com/discoveries/eagle-esophageal-ct","datePublished":"2026-09-25","dateModified":null,"sourcePublicationDate":"2026-09-22","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"A peer-reviewed study tested whether EAGLE, an AI system, could flag esophageal cancer on non-contrast chest CT scans people received for other reasons.","evidenceState":"Demonstrated","keyFacts":[{"label":"AI’s role","value":"A deep-learning system analyzed non-contrast chest CT scans for signs of esophageal cancer and high-grade intraepithelial neoplasia, including scans acquired for other reasons."},{"label":"Documented result","value":"Across 11,466 patients at eight external centres, EAGLE flagged 90.0% of known cancers (sensitivity) and correctly left 98.5% of patients without cancer unflagged (specificity). It flagged 60.1% of stage I cancers and 52.5% of precancerous lesions. In a separate prospective cohort of 17,446 patients at one hospital, it flagged 87.8% of known cancers. Of 90 alerts, 38 were confirmed malignant—36 cancers and two high-grade intraepithelial neoplasias—so 42.2% of alerts were confirmed malignant (positive predictive value)."},{"label":"Important limitation","value":"The prospective cohort had incomplete follow-up: among 52 people without confirmed malignancy, 28 had other findings, 19 were negative or had no symptoms, and five were lost to follow-up."}],"limitations":["The prospective cohort had incomplete follow-up: among 52 people without confirmed malignancy, 28 had other findings, 19 were negative or had no symptoms, and five were lost to follow-up.","The 10,959-person low-dose CT cohort was retrospective and single-site. Eight people were flagged, one cancer was confirmed, and five did not undergo endoscopy, so its 12.5% positive predictive value is not a complete screening outcome.","External sensitivity for stage I cancer was 60.1% and for precancerous lesions was 52.5%; the study does not show reduced mortality or better patient outcomes.","The authors call for broader international validation. DAMO Academy (Hupan Lab) was the main funder, and eight authors reported Alibaba employment and stock compensation."],"evidenceLinks":[{"title":"Large-scale esophageal cancer screening through noncontrast computed tomography and artificial intelligence · Nature Medicine","url":"https://www.nature.com/articles/s41591-026-04656-4","type":"paper"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/eagle-esophageal-ct","embedUrl":"https://brightaifuture.com/embed/story/eagle-esophageal-ct","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"bridges2-childhood-genomics","headline":"Pittsburgh research computing helped test genomic risk signals—not a medical test.","canonicalUrl":"https://brightaifuture.com/discoveries/bridges2-childhood-genomics","datePublished":"2026-09-19","dateModified":null,"sourcePublicationDate":null,"author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["data-centers","biology"],"summary":"A Northwestern-led team used Pittsburgh Supercomputing Center’s Bridges-2 system to compare 211 childhood sudden-death genomes with 211 matched controls and reported associations for future study.","evidenceState":"Demonstrated","keyFacts":[{"label":"AI’s role","value":"Research computing supported genomic analysis; the cited account does not establish an autonomous diagnosis or an AI screening product."},{"label":"Documented result","value":"Pittsburgh Supercomputing Center reports that a Northwestern-led team used Bridges-2 to compare 211 childhood sudden-death genomes with 211 matched controls and found genomic associations and risk signals for further investigation."},{"label":"Important limitation","value":"The study does not establish a clinical diagnostic, prevention method or population-screening tool."}],"limitations":["The study does not establish a clinical diagnostic, prevention method or population-screening tool.","A cohort of 211 cases limits power for rare variants and subgroup analysis.","Association does not establish that a variant caused a death."],"evidenceLinks":[{"title":"DNA and childhood sudden death","url":"https://www.psc.edu/dna-childhood/","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/bridges2-childhood-genomics","embedUrl":"https://brightaifuture.com/embed/story/bridges2-childhood-genomics","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"robin-dry-amd-hypothesis","headline":"A laboratory lead for dry AMD, not yet a treatment.","canonicalUrl":"https://brightaifuture.com/discoveries/robin-dry-amd-hypothesis","datePublished":"2026-09-19","dateModified":null,"sourcePublicationDate":"2026-05-19","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"Researchers used an AI system called Robin to connect biological evidence and identify a candidate direction for dry age-related macular degeneration, then tested it in laboratory models.","evidenceState":"Experimental","keyFacts":[{"label":"AI’s role","value":"Robin helped prioritize a biological hypothesis from heterogeneous evidence for laboratory testing."},{"label":"Documented result","value":"The Nature paper reports supporting in-vitro experiments. It does not report a human trial or clinical benefit."},{"label":"Important limitation","value":"Evidence is in vitro only."}],"limitations":["Evidence is in vitro only.","A mechanistic laboratory result may fail in animals or humans.","The model's prioritization does not establish causality on its own."],"evidenceLinks":[{"title":"A multi-agent system for automating scientific discovery","url":"https://www.nature.com/articles/s41586-026-10652-y","type":"paper"},{"title":"Age-Related Macular Degeneration (AMD)","url":"https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/robin-dry-amd-hypothesis","embedUrl":"https://brightaifuture.com/embed/story/robin-dry-amd-hypothesis","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"universal-cell-embedding","headline":"One coordinate system for cells across species.","canonicalUrl":"https://brightaifuture.com/discoveries/universal-cell-embedding","datePublished":"2026-09-19","dateModified":null,"sourcePublicationDate":"2026-07-08","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"Universal Cell Embedding was trained across 36 million cells, more than 1,000 cell types, and eight species to create reusable representations for cell biology.","evidenceState":"Demonstrated","keyFacts":[{"label":"AI’s role","value":"The model learned a common numerical representation of cells from large single-cell datasets."},{"label":"Documented result","value":"The Nature paper reports a corpus of 36 million cells spanning more than 1,000 cell types and eight species, with benchmarked downstream analyses detailed in the paper."},{"label":"Important limitation","value":"An embedding compresses data and can hide important biological variation."}],"limitations":["An embedding compresses data and can hide important biological variation.","Training-data coverage and annotation quality shape what transfers.","Cross-species similarity is not proof of identical function."],"evidenceLinks":[{"title":"Universal cell embedding provides a foundation model for cell biology","url":"https://www.nature.com/articles/s41586-026-10689-z","type":"paper"},{"title":"Tabula Sapiens","url":"https://tabula-sapiens-portal.ds.czbiohub.org/","type":"dataset"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/universal-cell-embedding","embedUrl":"https://brightaifuture.com/embed/story/universal-cell-embedding","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"medcognetics-mammography-workflow","headline":"Twelve millimetres, or three centimetres.","canonicalUrl":"https://brightaifuture.com/discoveries/medcognetics-mammography-workflow","datePublished":"2026-09-09","dateModified":"2026-09-12","sourcePublicationDate":"2025-12-11","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"A breast cancer found by imaging is typically about 12 mm across. One found by a hand — a woman's own, or a clinician's — is typically about 21 mm. In India, where almost no one is screened, four out of five recorded tumours are already 3 cm or larger when they are found.","evidenceState":"Emerging","keyFacts":[{"label":"AI’s role","value":"MedCognetics' cleared software does one narrow thing: it flags an exam so that suspicious studies rise in the radiologist's reading queue. FDA cleared it for triage and worklist prioritization only. It does not mark lesions, does not remove a study from the queue, and must not be relied on to make or confirm a diagnosis. A radiologist still reads everything."},{"label":"Documented result","value":"MedCognetics holds two FDA 510(k) clearances for mammography triage: K220080, cleared 29 September 2022, and K252482, cleared 11 December 2025. NVIDIA reported in October 2025 that the software runs on mobile screening vans operated by Health Within Reach in India, and that more than 3,500 women had been screened; that account is the companies' own."},{"label":"Important limitation","value":"The screening numbers and any account of lives saved come from the participating companies. No independent evaluation, audit or named patient exists, and early detection is not the same as a life saved."}],"limitations":["The screening numbers and any account of lives saved come from the participating companies. No independent evaluation, audit or named patient exists, and early detection is not the same as a life saved.","The cleared indication is triage only. It is not a diagnostic device, and its own labelling notes reduced performance for dense breasts and small lesions — common in the younger population it is deployed among.","The strongest trial evidence for AI in mammography, MASAI in Sweden, did not measure mortality and ran in a mature organised double-reading programme, a setting almost unlike rural India.","Screening only helps if treatment follows. In a documented Indian camp programme in Varanasi district, only 220 of 732 people who screened positive — 30.1% — completed follow-up, despite free transport and diagnostics."],"evidenceLinks":[{"title":"FDA 510(k) clearance K252482 — CogNet AI-MT+ (MedCognetics)","url":"https://www.accessdata.fda.gov/cdrh_docs/pdf25/K252482.pdf","type":"government"},{"title":"Metastatic presentation of breast cancer in India: evidence from the national cancer registry (2009–2020) · Lancet Regional Health SE Asia","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13092702/","type":"paper"},{"title":"Tumor size and detection in breast cancer: self-examination and clinical breast examination are at their limit · Cancer Detection and Prevention","url":"https://doi.org/10.1016/j.cdp.2008.04.002","type":"paper"},{"title":"Female cancer screening in India: uptake and inequality, NFHS-5","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11610822/","type":"paper"},{"title":"Community-based cancer screening at primary care level in Varanasi district · BMJ Open","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10729271/","type":"paper"},{"title":"AI-supported screen reading versus standard double reading (MASAI) · The Lancet","url":"https://www.thelancet.com/journals/landig/article/PIIS2589-7500(24)00267-X/fulltext","type":"paper"},{"title":"MedCognetics: mammography workflow","url":"https://www.medcognetics.com/","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/medcognetics-mammography-workflow","embedUrl":"https://brightaifuture.com/embed/story/medcognetics-mammography-workflow","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"ge-autonomous-imaging-development","headline":"An imaging system learns first in simulation.","canonicalUrl":"https://brightaifuture.com/discoveries/ge-autonomous-imaging-development","datePublished":"2026-09-09","dateModified":null,"sourcePublicationDate":"2025-03-18","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["robotics","biology"],"summary":"NVIDIA and GE HealthCare announced work on autonomous X-ray and ultrasound development using medical-device simulation.","evidenceState":"Emerging","keyFacts":[{"label":"AI’s role","value":"NVIDIA says Isaac for Healthcare supplies models and physics-based simulations for training, testing and validating capabilities before physical deployment."},{"label":"Documented result","value":"The March 2025 announcement names GE HealthCare as a collaborator."},{"label":"Important limitation","value":"The release says many features remain in development and are forward-looking; it is not a clearance, deployment or diagnostic-accuracy result."}],"limitations":["The release says many features remain in development and are forward-looking; it is not a clearance, deployment or diagnostic-accuracy result."],"evidenceLinks":[{"title":"NVIDIA: GE HealthCare autonomous imaging collaboration","url":"https://nvidianews.nvidia.com/news/nvidia-and-ge-healthcare-collaborate-to-advance-the-development-of-autonomous-diagnostic-imaging-with-physical-ai","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/ge-autonomous-imaging-development","embedUrl":"https://brightaifuture.com/embed/story/ge-autonomous-imaging-development","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"gluformer","headline":"Reading patterns in glucose over time.","canonicalUrl":"https://brightaifuture.com/discoveries/gluformer","datePublished":"2026-09-09","dateModified":null,"sourcePublicationDate":"2025-01-07","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"GluFormer researchers trained a model on continuous glucose readings to study metabolic patterns and prediction.","evidenceState":"Experimental","keyFacts":[{"label":"AI’s role","value":"A generative model learns representations from glucose time series."},{"label":"Documented result","value":"The authors report tests across external cohorts and associations with later health measures."},{"label":"Important limitation","value":"This linked version is a preprint. Predictive associations do not establish a treatment benefit or individual diagnosis."}],"limitations":["This linked version is a preprint. Predictive associations do not establish a treatment benefit or individual diagnosis."],"evidenceLinks":[{"title":"GluFormer research preprint, version 2","url":"https://arxiv.org/abs/2408.11876v2","type":"paper"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/gluformer","embedUrl":"https://brightaifuture.com/embed/story/gluformer","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"jnj-digital-surgery-mou","headline":"A surgical ecosystem tests an edge.","canonicalUrl":"https://brightaifuture.com/discoveries/jnj-digital-surgery-mou","datePublished":"2026-09-09","dateModified":null,"sourcePublicationDate":"2024-03-18","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["robotics","biology"],"summary":"J&J MedTech and NVIDIA announced an MOU to test AI capabilities for a connected digital surgery ecosystem.","evidenceState":"Emerging","keyFacts":[{"label":"AI’s role","value":"The announcement names NVIDIA IGX and Holoscan as infrastructure for AI-powered applications."},{"label":"Documented result","value":"The companies announced testing and an MOU on March 18, 2024."},{"label":"Important limitation","value":"Both sources describe forward-looking work, not a demonstrated clinical outcome or independent performance evidence."}],"limitations":["Both sources describe forward-looking work, not a demonstrated clinical outcome or independent performance evidence."],"evidenceLinks":[{"title":"NVIDIA: J&J MedTech AI surgery report","url":"https://blogs.nvidia.com/blog/johnson-and-johnson-medtech-ai-surgery/","type":"institution"},{"title":"J&J: working with NVIDIA to scale AI for surgery","url":"https://www.jnj.com/media-center/press-releases/johnson-johnson-medtech-working-with-nvidia-to-scale-ai-for-surgery","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/jnj-digital-surgery-mou","embedUrl":"https://brightaifuture.com/embed/story/jnj-digital-surgery-mou","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"moon-maestro-ai-capabilities","headline":"A surgical platform explores new AI capabilities.","canonicalUrl":"https://brightaifuture.com/discoveries/moon-maestro-ai-capabilities","datePublished":"2026-09-09","dateModified":null,"sourcePublicationDate":"2025-03-18","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["robotics","biology"],"summary":"Moon Surgical's news index lists 2025 NVIDIA Isaac and Holoscan announcements for its Maestro platform.","evidenceState":"Emerging","keyFacts":[{"label":"AI’s role","value":"Moon says it would accelerate AI capabilities with NVIDIA Isaac for Healthcare and describes ScoPilot as AI-enhanced and Holoscan-powered."},{"label":"Documented result","value":"Its index dates both items March 18, 2025."},{"label":"Important limitation","value":"A company news index does not establish patient benefit or make every Maestro procedure AI-driven."}],"limitations":["A company news index does not establish patient benefit or make every Maestro procedure AI-driven."],"evidenceLinks":[{"title":"Moon Surgical: Maestro news index","url":"https://www.moonsurgical.com/","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/moon-maestro-ai-capabilities","embedUrl":"https://brightaifuture.com/embed/story/moon-maestro-ai-capabilities","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"nvidia-biopharma-workflows","headline":"Molecule proposals return to the lab.","canonicalUrl":"https://brightaifuture.com/discoveries/nvidia-biopharma-workflows","datePublished":"2026-09-09","dateModified":null,"sourcePublicationDate":null,"author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"NVIDIA describes Genentech and Amgen drug-discovery workflows using generative AI.","evidenceState":"Emerging","keyFacts":[{"label":"AI’s role","value":"NVIDIA says Amgen uses models to propose and evaluate candidates; it describes a Genentech lab-in-the-loop collaboration."},{"label":"Documented result","value":"The page presents named workflow examples, not a treatment result."},{"label":"Important limitation","value":"The reviewed source supplies no Novo Nordisk-specific example and no independently verified faster, lower-cost or patient outcome."}],"limitations":["The reviewed source supplies no Novo Nordisk-specific example and no independently verified faster, lower-cost or patient outcome."],"evidenceLinks":[{"title":"NVIDIA: AI-powered drug discovery","url":"https://www.nvidia.com/en-us/industries/healthcare-life-sciences/drug-discovery/","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/nvidia-biopharma-workflows","embedUrl":"https://brightaifuture.com/embed/story/nvidia-biopharma-workflows","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"simbiosys","headline":"An MRI becomes a spatial view.","canonicalUrl":"https://brightaifuture.com/discoveries/simbiosys","datePublished":"2026-09-09","dateModified":null,"sourcePublicationDate":"2024-10-31","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"SimBioSys TumorSight Viz turns breast MRI images into three-dimensional views for surgical planning, according to NVIDIA’s report.","evidenceState":"Emerging","keyFacts":[{"label":"AI’s role","value":"Imaging models support segmentation and 3D visualization."},{"label":"Documented result","value":"The report describes volumetric tissue views and surgery-related measurements."},{"label":"Important limitation","value":"The visualization is not evidence of improved survival. Clinical utility and regulatory indications require their own assessment."}],"limitations":["The visualization is not evidence of improved survival. Clinical utility and regulatory indications require their own assessment."],"evidenceLinks":[{"title":"NVIDIA: SimBioSys 3D breast imaging report","url":"https://blogs.nvidia.com/blog/simbiosys-3d-visualizations-breast-cancer-tumors/","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/simbiosys","embedUrl":"https://brightaifuture.com/embed/story/simbiosys","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"virtual-incision-isaac-exploration","headline":"A miniaturized robot explores a simulation platform.","canonicalUrl":"https://brightaifuture.com/discoveries/virtual-incision-isaac-exploration","datePublished":"2026-09-09","dateModified":null,"sourcePublicationDate":"2025-03-18","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["robotics","biology"],"summary":"Virtual Incision lists a 2025 announcement that it explores NVIDIA Isaac for Healthcare in surgical robotics.","evidenceState":"Emerging","keyFacts":[{"label":"AI’s role","value":"The company identifies MIRA as a miniaturized robotic-assisted surgery system and separately names the Isaac exploration."},{"label":"Documented result","value":"The announcement is dated March 18, 2025 in the company's news index."},{"label":"Important limitation","value":"Virtual Incision warns that outcomes vary and that safety/effectiveness evaluation is procedure-specific. The announcement does not prove NVIDIA AI use in every operating room."}],"limitations":["Virtual Incision warns that outcomes vary and that safety/effectiveness evaluation is procedure-specific. The announcement does not prove NVIDIA AI use in every operating room."],"evidenceLinks":[{"title":"Virtual Incision: MIRA and NVIDIA Isaac news index","url":"https://www.virtualincision.com/","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/virtual-incision-isaac-exploration","embedUrl":"https://brightaifuture.com/embed/story/virtual-incision-isaac-exploration","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"wellcome-sanger","headline":"More room to read cancer genomes.","canonicalUrl":"https://brightaifuture.com/discoveries/wellcome-sanger","datePublished":"2026-09-09","dateModified":null,"sourcePublicationDate":"2024-09-23","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"Wellcome Sanger Institute explored accelerated genome analysis using NVIDIA Parabricks and GPU systems.","evidenceState":"Emerging","keyFacts":[{"label":"AI’s role","value":"GPU acceleration supports genomic analysis; acceleration itself is not proof of an AI-discovered treatment."},{"label":"Documented result","value":"NVIDIA reported Sanger’s use and evaluation of accelerated analysis workflows."},{"label":"Important limitation","value":"The partner report does not establish a patient outcome. Runtime and energy comparisons apply to specified systems and workloads."}],"limitations":["The partner report does not establish a patient outcome. Runtime and energy comparisons apply to specified systems and workloads."],"evidenceLinks":[{"title":"NVIDIA: Wellcome Sanger genome analysis report","url":"https://blogs.nvidia.com/blog/wellcome-sanger-institute-cancer-research/","type":"institution"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/wellcome-sanger","embedUrl":"https://brightaifuture.com/embed/story/wellcome-sanger","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"alphagenome-variant-effects","headline":"Reading more of a DNA change's consequences","canonicalUrl":"https://brightaifuture.com/discoveries/alphagenome-variant-effects","datePublished":"2026-09-07","dateModified":null,"sourcePublicationDate":"2026-01-28","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"AlphaGenome is a unified DNA-sequence model that takes up to 1 Mb of DNA and predicts thousands of functional genomic tracks, including gene expression, splicing, chromatin features, transcription-factor binding, and contact maps.","evidenceState":"Demonstrated","keyFacts":[{"label":"AI’s role","value":"A deep-learning model jointly predicts many molecular genomic measurements and scores the likely effect of a sequence variant across those modalities."},{"label":"Documented result","value":"In the paper's external variant-effect evaluations, AlphaGenome matched or exceeded the strongest available external models in 25 of 26 evaluations; it also recapitulated mechanisms of clinically relevant variants near the TAL1 oncogene."},{"label":"Important limitation","value":"The model predicts molecular effects; it does not diagnose a patient, establish causal disease mechanisms, or prove a treatment works."}],"limitations":["The model predicts molecular effects; it does not diagnose a patient, establish causal disease mechanisms, or prove a treatment works.","Training and evaluation draw on existing human and mouse experimental datasets.","The paper describes non-commercial API access, not universal clinical availability."],"evidenceLinks":[{"title":"Advancing regulatory variant effect prediction with AlphaGenome","url":"https://www.nature.com/articles/s41586-025-10014-0","type":"paper"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/alphagenome-variant-effects","embedUrl":"https://brightaifuture.com/embed/story/alphagenome-variant-effects","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"abaucin","headline":"A new lead against resistant bacteria.","canonicalUrl":"https://brightaifuture.com/discoveries/abaucin","datePublished":"2026-09-05","dateModified":null,"sourcePublicationDate":"2023-05-25","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"Scientists identified abaucin, a compound active against Acinetobacter baumannii, with help from deep learning.","evidenceState":"Experimental","keyFacts":[{"label":"AI’s role","value":"A model prioritized compounds for laboratory testing."},{"label":"Documented result","value":"Abaucin showed activity in experiments, including a mouse wound infection model."},{"label":"Important limitation","value":"Preclinical evidence. Human safety and efficacy are not established."}],"limitations":["Preclinical evidence. Human safety and efficacy are not established."],"evidenceLinks":[{"title":"Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii · Nature Chemical Biology","url":"https://www.nature.com/articles/s41589-023-01349-8","type":"paper"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/abaucin","embedUrl":"https://brightaifuture.com/embed/story/abaucin","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"af3","headline":"Seeing molecules together.","canonicalUrl":"https://brightaifuture.com/discoveries/af3","datePublished":"2026-09-05","dateModified":null,"sourcePublicationDate":"2024-05-08","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"AlphaFold 3 expanded structural prediction to complexes of proteins and other biomolecules.","evidenceState":"Demonstrated","keyFacts":[{"label":"AI’s role","value":"A diffusion-based model predicted joint molecular structures."},{"label":"Documented result","value":"The work improved performance across several interaction benchmarks."},{"label":"Important limitation","value":"Structural predictions are not proof of binding, biological function, or clinical efficacy."}],"limitations":["Structural predictions are not proof of binding, biological function, or clinical efficacy."],"evidenceLinks":[{"title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","url":"https://www.nature.com/articles/s41586-024-07487-w","type":"paper"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/af3","embedUrl":"https://brightaifuture.com/embed/story/af3","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"mrsa","headline":"Looking for new antibiotic families.","canonicalUrl":"https://brightaifuture.com/discoveries/mrsa","datePublished":"2026-09-05","dateModified":null,"sourcePublicationDate":"2023-12-20","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"Researchers used explainable deep learning to identify a structural class of antibiotic candidates.","evidenceState":"Experimental","keyFacts":[{"label":"AI’s role","value":"Models predicted activity and highlighted chemical substructures."},{"label":"Documented result","value":"Candidate compounds showed antibacterial activity, including tests in mouse models."},{"label":"Important limitation","value":"Preclinical findings do not demonstrate human safety or effectiveness."}],"limitations":["Preclinical findings do not demonstrate human safety or effectiveness."],"evidenceLinks":[{"title":"Discovery of a structural class of antibiotics with explainable deep learning","url":"https://www.nature.com/articles/s41586-023-06887-8","type":"paper"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/mrsa","embedUrl":"https://brightaifuture.com/embed/story/mrsa","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},{"id":"proteome","headline":"A broader map of human proteins.","canonicalUrl":"https://brightaifuture.com/discoveries/proteome","datePublished":"2026-09-05","dateModified":null,"sourcePublicationDate":"2021-07-22","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"Researchers applied AlphaFold to a broad collection of human proteins.","evidenceState":"Demonstrated","keyFacts":[{"label":"AI’s role","value":"AlphaFold predicted structures across the human proteome."},{"label":"Documented result","value":"The study supplied predictions with per-region confidence estimates."},{"label":"Important limitation","value":"Coverage is not uniform accuracy; disordered regions and low-confidence predictions need care."}],"limitations":["Coverage is not uniform accuracy; disordered regions and low-confidence predictions need care."],"evidenceLinks":[{"title":"Highly accurate protein structure prediction for the human proteome","url":"https://www.nature.com/articles/s41586-021-03828-1","type":"paper"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/proteome","embedUrl":"https://brightaifuture.com/embed/story/proteome","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}}],"documentation":"https://brightaifuture.com/wire/terms"}